Expression Systems

Expression Systems is a long-established, private biotechnology company providing essential tools for the baculovirus expression vector system (BEVS), a widely used platform for recombinant protein production and viral vector manufacturing. The company's primary value proposition is its high-performance, chemically defined insect cell culture media, which enables superior cell growth, viability, and product consistency for its global customer base. Operating as a B2B supplier, it generates revenue by selling media, cell lines, and associated services to academic, biopharma, and CDMO clients. Its strategic focus is on enhancing the efficiency and scalability of baculovirus-based processes, which are crucial for applications ranging from vaccine development to gene therapy.

Specialist in Baculovirus Expression Vector System (BEVS) tools, including chemically defined insect cell culture media (ESF AdvanCD™), engineered insect host cell lines (e.g., Sf9 RV-Free), and related reagents for recombinant protein and viral vector production.

Expression Systems competes with the insect cell media and reagent divisions of large conglomerates like Thermo Fisher Scientific and Merck Millipore. Its competitive advantage is deep, specialized expertise in BEVS optimization and high-performance, chemically defined media formulations tailored for demanding production applications.